Sign In
Buy COWN
$38.99
+0 (+0%)
At Close: May 26, 2023
HEALWELL to Participate in Upcoming TD Cowen, Scotiabank and ROTH Investor Conferences
07:00am, Friday, 27'th Feb 2026
46th Annual Health Care Conference on March 2-4, 2026, in Boston, MA 29th Annual Scotiabank TMT Conference on March 3-4, 2026, in Toronto, ON 38th Annual Roth Conference on March 22-24, 2026, in Dana
Rapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care Conference
04:15pm, Thursday, 26'th Feb 2026
LEXINGTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automatio
Royalty Pharma to Present at TD Cowen's 46th Annual Health Care Conference
04:15pm, Thursday, 26'th Feb 2026
NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen's 46th Annual Health Care Conference on March 3, 2
Milestone® Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference
08:00am, Thursday, 26'th Feb 2026
MONTREAL and CHARLOTTE, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that Amit Hasija, Chief Financial Officer, and Lorenz Muller, Chief Com
Korro to Present at the TD Cowen 46th Annual Health Care Conference
04:05pm, Wednesday, 25'th Feb 2026
CAMBRIDGE, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and hi
Enliven Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
04:05pm, Wednesday, 25'th Feb 2026
BOULDER, Colo., Feb. 25, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care Conference
04:01pm, Wednesday, 25'th Feb 2026
LONDON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the TD Cowen 46th Annual Hea
Vistagen to Participate in the 46th Annual TD Cowen Healthcare Conference
08:30am, Wednesday, 25'th Feb 2026
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commerci
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
08:00am, Wednesday, 25'th Feb 2026
BOSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunothera
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
08:00am, Wednesday, 25'th Feb 2026
SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapi
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference
08:00am, Wednesday, 25'th Feb 2026
BOSTON and ROLLE, Switzerland, Feb. 25, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced that leadership will present at TD Cowen'
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
08:00am, Wednesday, 25'th Feb 2026
PRINCETON, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, nov
Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference
07:30am, Wednesday, 25'th Feb 2026
NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative t
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference
07:27am, Wednesday, 25'th Feb 2026
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
07:00am, Wednesday, 25'th Feb 2026
WALTHAM, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell
